Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): Old truths and a new syndrome?

Journal of Autoimmunity

Volumn 36, Issue 1, 2011, Pages 1-3

  Meroni, Pier Luigi ^a,b  

^a ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Adjuvant; Autoimmunity; Vaccination

Indexed keywords

ALUMINUM; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; SILICONE;

ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE INFLAMMATORY SYNDROME INDUCED BY ADJUVANT; BREAST ENDOPROSTHESIS; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENE INTERACTION; GUILLAIN BARRE SYNDROME; HUMAN; INFLAMMATORY DISEASE; INNATE IMMUNITY; LONG TERM EXPOSURE; NONHUMAN; PRIORITY JOURNAL; RHEUMATIC FEVER; RISK FACTOR; STREPTOCOCCUS INFECTION; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; AUTOIMMUNE DISEASES; ENVIRONMENTAL EXPOSURE; HUMANS; INFLAMMATION; SYNDROME;

EID: 79151474770     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.10.004     Document Type: Article

References (67)

1. Shoenfeld Y., Agmon-Levin N. 'ASIA' autoimmune/auto inflammatory syndrome induced by adjuvant. J Autoimmun 2011, 36:4-8.
2. Agmon-Levin N., Paz Z., Israeli E., Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol 2009, 5:648-652.
3. Parmet W.E. Pandemic vaccines-the legal landscape. N Engl J Med 2010, 362:1949-1952.
4. Stewart A.M. Mandatory vaccination of health care workers. N Engl J Med 2009, 361:2015-2017.
5. Conti F., Rezai S., Valesini G. Vaccination and autoimmune rheumatic diseases. Autoimmun Rev 2008, 8:124-128.
6. Elkayam O., Ablin J., Caspi D. Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases. Autoimmun Rev 2007, 6:312-314.
7. Janowsky E.C., Kupper L.L., Hulka B.S. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med 2000, 342:781-790.
8. Evans D., Cauchemez S., Hayden F.G. "Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barre syndrome, and the detection of rare severe adverse events. J Infect Dis 2009, 200:321-328.
9. Shoenfeld Y., Cervera R., Gershwin M. Diagnostic criteria in autoimmune diseases 2008, Humana Press.
10. Fryzek J.P., Signorello L.B., Hakelius L., Feltelius N., Ringberg A., Blot W.J., et al. Self-reported symptoms among women after cosmetic breast implant and breast reduction surgery. Plast Reconstr Surg 2001, 107:206-213.
11. Vasey F.B., Zarabadi S.A., Seleznick M., Ricca L. Where there's smoke there's fire: the silicone breast implant controversy continues to flicker: a new disease that needs to be defined. J Rheumatol 2003, 30:2092-2094.
12. Zandman-Goddard G., Blank M., Ehrenfeld M., Gilburd B., Peter J., Shoenfeld Y. A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants. J Rheumatol 1999, 26:73-77.
13. Kivity S., Agmon-Levin N., Blank M., Shoenfeld Y. Infections and autoimmunity-friends or foes?. Trends Immunol 2009, 30:409-414.
14. Arbuckle M.R., McClain M.T., Rubertone M.V., Scofield R.H., Dennis G.J., James J.A., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003, 349:1526-1533.
15. Mikaeloff Y., Caridade G., Suissa S., Tardieu M. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 2009, 72:873-880.
16. Eisenbarth S.C., Colegio O.R., O'Connor W., Sutterwala F.S., Flavell R.A. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008, 453:1122-1126.
17. Israeli E., Agmon-Levin N., Blank M., Shoenfeld Y. Adjuvants and autoimmunity. Lupus 2009, 18:1217-1225.
18. Kool M., Soullie T., van Nimwegen M., Willart M.A., Muskens F., Jung S., et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med 2008, 205:869-882.
19. Carlson B.C., Jansson A.M., Larsson A., Bucht A., Lorentzen J.C. The endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats. Am J Pathol 2000, 156:2057-2065.
20. Reeves W.H., Lee P.Y., Weinstein J.S., Satoh M., Lu L. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol 2009, 30:455-464.
21. Chang C., Gershwin M.E. Indoor air quality and human health: truth vs mass hysteria. Clin Rev Allergy Immunol 2004, 27:219-239.
22. Lerner A. Aluminum is a potential environmental factor for Crohn's disease induction: extended hypothesis. Ann N Y Acad Sci 2007, 1107:329-345.
23. Rose N.R. Autoimmunity, infection and adjuvants. Lupus 2010, 19:354-358.
24. Tsai Y.J., Gershwin M.E. The sick building syndrome: what is it when it is?. Compr Ther 2002, 28:140-144.
25. Shaw C.A., Petrik M.S. Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration. J Inorg Biochem 2009, 103:1555-1562.
26. Kumar V., Gill K.D. Aluminium neurotoxicity: neurobehavioural and oxidative aspects. Arch Toxicol 2009, 83:965-978.
27. Arnson Y., Shoenfeld Y., Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010, 34:J258-J265.
28. Berkun Y., Padeh S. Environmental factors and the geoepidemiology of juvenile idiopathic arthritis. Autoimmun Rev 2010, 9:A319-A324.
29. Bhat A., Naguwa S., Cheema G., Gershwin M.E. The epidemiology of transverse myelitis. Autoimmun Rev 2010, 9:A395-A399.
30. Biggioggero M., Meroni P.L. The geoepidemiology of the antiphospholipid antibody syndrome. Autoimmun Rev 2010, 9:A299-A304.
31. Borchers A.T., Naguwa S.M., Keen C.L., Gershwin M.E. The implications of autoimmunity and pregnancy. J Autoimmun 2010, 34:J287-J299.
32. Borchers A.T., Naguwa S.M., Shoenfeld Y., Gershwin M.E. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010, 9:A277-A287.
33. Borchers A.T., Uibo R., Gershwin M.E. The geoepidemiology of type 1 diabetes. Autoimmun Rev 2010, 9:A355-A365.
34. Brooks W.H., Le Dantec C., Pers J.O., Youinou P., Renaudineau Y. Epigenetics and autoimmunity. J Autoimmun 2010, 34:J207-J219.
35. Chandran V., Raychaudhuri S.P. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 2010, 34:J314-J321.
36. Chang C. The immune effects of naturally occurring and synthetic nanoparticles. J Autoimmun 2010, 34:J234-J246.
37. Chang C., Gershwin M.E. Drugs and autoimmunity-a contemporary review and mechanistic approach. J Autoimmun 2010, 34:J266-J275.
38. Chen M., Daha M.R., Kallenberg C.G. The complement system in systemic autoimmune disease. J Autoimmun 2010, 34:J276-J286.
39. Chen M., Kallenberg C.G. The environment, geoepidemiology and ANCA-associated vasculitides. Autoimmun Rev 2010, 9:A293-A298.
40. Deane S., Teuber S.S., Gershwin M.E. The geoepidemiology of immune thrombocytopenic purpura. Autoimmun Rev 2010, 9:A342-A349.
41. Ehrenfeld M. Geoepidemiology: the environment and spondyloarthropathies. Autoimmun Rev 2010, 9:A325-A329.
42. Hemminki K., Li X., Sundquist J., Sundquist K. The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution. J Autoimmun 2010, 34:J307-J313.
43. Hoffmann M.H., Trembleau S., Muller S., Steiner G. Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential. J Autoimmun 2010, 34:J178-J206.
44. Invernizzi P. Geoepidemiology of autoimmune liver diseases. J Autoimmun 2010, 34:J300-J306.
45. Lambert J.F., Nydegger U.E. Geoepidemiology of autoimmune hemolytic anemia. Autoimmun Rev 2010, 9:A350-A354.
46. Leung P.S., Shu S.A., Kenny T.P., Wu P.Y., Tao M.H. Development and validation of gene therapies in autoimmune diseases: epidemiology to animal models. Autoimmun Rev 2010, 9:A400-A405.
47. Lleo A., Invernizzi P., Gao B., Podda M., Gershwin M.E. Definition of human autoimmunity-autoantibodies versus autoimmune disease. Autoimmun Rev 2010, 9:A259-A266.
48. Logan I., Bowlus C.L. The geoepidemiology of autoimmune intestinal diseases. Autoimmun Rev 2010, 9:A372-A378.
49. Mackay I.R. Travels and travails of autoimmunity: a historical journey from discovery to rediscovery. Autoimmun Rev 2010, 9:A251-A258.
50. Maverakis E., Miyamura Y., Bowen M.P., Correa G., Ono Y., Goodarzi H. Light, including ultraviolet. J Autoimmun 2010, 34:J247-J257.
51. Mavragani C.P., Moutsopoulos H.M. The geoepidemiology of Sjogren's syndrome. Autoimmun Rev 2010, 9:A305-A310.
52. Meyer N., Misery L. Geoepidemiologic considerations of auto-immune pemphigus. Autoimmun Rev 2010, 9:A379-A382.
53. Milo R., Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 2010, 9:A387-A394.
54. Powell J.J., Faria N., Thomas-McKay E., Pele L.C. Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun 2010, 34:J226-J233.
55. Prieto S., Grau J.M. The geoepidemiology of autoimmune muscle disease. Autoimmun Rev 2010, 9:A330-A334.
56. Ranque B., Mouthon L. Geoepidemiology of systemic sclerosis. Autoimmun Rev 2010, 9:A311-A318.
57. Round J.L., O'Connell R.M., Mazmanian S.K. Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun 2010, 34:J220-J225.
58. Sands J., Tuscano J.M. Geoepidemiology and autoimmune manifestations of lymphoproliferative disorders. Autoimmun Rev 2010, 9:A335-A341.
59. Segelmark M., Hellmark T. Autoimmune kidney diseases. Autoimmun Rev 2010, 9:A366-A371.
60. Selmi C. The worldwide gradient of autoimmune conditions. Autoimmun Rev 2010, 9:A247-A250.
61. Selmi C., Tsuneyama K. Nutrition, geoepidemiology, and autoimmunity. Autoimmun Rev 2010, 9:A267-A270.
62. Shapira Y., Agmon-Levin N., Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 2010, 34:J168-J177.
63. Stojanovich L. Stress and autoimmunity. Autoimmun Rev 2010, 9:A271-A276.
64. Tobon G.J., Youinou P., Saraux A. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. Autoimmun Rev 2010, 9:A288-A292.
65. Tomer Y. Hepatitis C and interferon induced thyroiditis. J Autoimmun 2010, 34:J322-J326.
66. Agmon-Levin N., Shapira Y., Selmi C., Barzilai O., Ram M., Szyper-Kravitz M., et al. A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J Autoimmun 2010, 34:55-58.
67. Zeki A.A., Schivo M., Chan A.L., Hardin K.A., Kenyon N.J., Albertson T.E., et al. Geoepidemiology of COPD and idiopathic pulmonary fibrosis. J Autoimmun 2010, 34:J327-J338.